(A~) concentration in the cerebrospinal fluid (CSF)of the brain may be regulated by the choroid plexus, which forms a barrier between blood and brain CSF. A~uptake from CSF was determined as its volume of distribution (V o) into isolated rat choroid plexus tissue. The V o of [1251] A~1-4o was corrected by SUbtraction of the V o of [ 14C]sucrose, a marker for extracellular space and diffusion. Ap uptake into choroid plexus was time and temperature dependent. Uptake of [ 1251]AP was saturable. Ap Uptake was not affected by addition of transthyretln or apolipoprotein E3. In studies with primary culture monolayers of choroidal epithelial cells in Transwells, Ap permeability across cells, corrected by [ 14C]sucrose, was greater from the CSF-faclng membrane than from the blood-facing membrane. Similarly, cellular accumulation of [ 1251]AP was concentrative from both directions and was greater from the CSF·facing membrane, suggesting a bias for efflux. Overall, these results Suggest the choroid plexus selectively cleanses Ap from the CSF by an undetermined mechanism(s), potentially reducing Ap from normal brains and the brains of Alzheimer's disease patients. Exp Bioi Med 230: [771][772][773][774][775][776]2005 
the blood. The blood-brain barrier (BBB). whose structural basis is the tightly connected cerebral capillary endothelia, occurs between the blood and cerebral interstitial fluid. The flux of A~at the BBB has been described (3) . The bloodcerebrospinal fluid barrier (BCB) separates blood from the cerebrospinal fluid (CSF) circulating within the brain. The BCB occurs at the choroid plexus tissue, which transports materials into the brain by CSF secretion and serves as a primary site for efflux or clearance of brain metabolites eluted from the interstitial fluid to the ventricular CSF (4) . The mechanisms by which the brain metabolizes and eliminates A~, specifically at the BCB, are poorly understood.
A~is present in the CSF of normal and AD brains. The CSF concentration ratio of two A~peptides (A~I-4o to A~I-42) is a suggested biomarker for AD, although the individual concentrations of the two peptides are variable among AD patients (5, 6) . A~accumulation occurs within the choroid plexus epithelia of AD patients (7) . It is unknown whether the choroid plexus plays any role in Aã ccumulation in AD; even less is known about how aging, disease, or toxicant exposure conditions that affect choroid plexus function may interfere with the homeostasis of A~in the CSF.
This study examined the kinetic aspect of uptake, accumulation, and transport of A~by the choroid plexus. We used isolated rat choroid plexus tissues to examine net A~I-4o uptake. Freshly isolated choroid plexus tissue maintains the primary characteristics of the BCB and is an ideal model system for obtaining the essential uptake parameters at the BCB. A~I-4o was selected as a model compound for all A~peptides because of its optimal solubility. We also used the primary culture of choroidal epithelial cells to investigate the direction of A~transport by the choroid plexus and the intracellular accumulation at equilibrium. Our objective was to determine whether the BCB played an important role in A~homeostasis within the CSF from which to understand the role of BCB in AD causation, progression, and in the design of therapeutic strategy.
Materials and Methods
Materials. Male Sprague-Dawley rats were purchased from Harlan Laboratory Animals (Indianapolis, IN). Materi-als were purchased from the following sources: e25I]A~I-40 (1700-2000 Ci/mmol) from Amersham Biosciences (piscataway, NJ) and Phoenix Pharmaceuticals (Belmont, CA), e 4 C]sucrose from Moravek (Brea, CA), cell culture reagents from Invitrogen (Carlsbad, CA), Coming Tmnswell-COL chambers (1 cm 2 growing space, 0.4 um pore size) from VWR (Batavia, IL), and pronase from EMD Biosciences (La Jolla, CA). All other chemicals were purchased from Sigma (St.
Louis, MO). Culture medium and serum-free medium were prepared as previously described (8) ,~Uptake inhibitors or A~binding agents were added to some artificial CSF solutions to measure their effects. After the time course study, an uptake time of 2 mins was selected for subsequent studies to maintain the kinetics within the linear portion of the uptake curve, where the uptake is not significantly confounded by substrate back flux from the tissue. To end the incubation, the tissue was removed from artificial CSF, dragged along a plastic slide to remove excess fluid, and solubilized. For studies of total 1251 label, the tissue was solubilized in NaOH (1 M) and neutralized with equimolar HC!. In filtered [1251]A~uptake studies, the choroid plexuses were solubilized in artificial CSF containing I % Triton X-100 at 4°C, followed by tissue centrifugation through a 3000 daltons mol wt cutoff membrane (14, Primary Culture ofChoroidal Epithelial Cells. Primary cultures of choroid plexus epithelial cells were obtained as previously described (8) . Briefly, rats (150-175 g) were anesthetized and killed as described above. The brains were removed under aseptic conditions and immediately placed in ice-cold, sterile PBS. The choroid plexuses from the lateral, third, and fourth ventricles were removed. Pooled tissue was minced mechanically and digested with pronase (2 mg/ml) at 37°C for 10-15 mins. Isolated cells were washed and plated at 2 X 10 5 cells/Transwell insert (1 crrr') in culture medium. Ap Flux Studies. The formation of a barrier between two chambers was considered mature if it met the three following criteria: a difference in fluid height between chambers, a transepithelial electrical resistance above 80 Qcm 2, and a [14C]sucrose permeability below 8 X 10-4 em/ min; the latter two values were within those reported in literature (8, 9) . Cells were washed three times in 37°C serum-free medium (SFM) and allowed to equilibrate for 10 mins. The final wash was replaced with SFM in the receiver chamber and SFM plus e251]A~(0.5-1 IlCi/ml) and
[14C]sucrose (0.1-0.5 IlCi/ml) in the donor chamber. For influx experiments, the outer chamber was the donor chamber; for efflux, the inner chamber was the donor chamber. Cell viability, measured by methylthiazolyldiphenyltetrazolium bromide (MIT) conversion to its formazan product in a parallel study, was not changed for at least 2 hrs when the cells were cultured in SFM (data not shown). Medium aliquots (10 ilL;::; 2% total volume) were removed from the receiver chamber at designated times and replaced with tracer-free SFM. At the end of the flux experiment, the inserts were washed 3 times in ice-cold, radioisotope-free SFM. Each filter was removed and placed in 0.2 M NaOH containing 1% SDS (0.5 ml) to solubilize the cells. The cell Iysates were neutralized by equimolar HCl. Aliquots of cell lysates were disbursed to determine [1251]A~and [ 14C]SU_ erose uptake by liquid scintillation analysis and total protein by the bicinchoninic acid method, Data Analysis. The volume of distribution (VD) was calculated as the ratio of tissue uptake (dpm/g tissue) to medium concentration (dpm/ml), The total 125 1 results were corrected for extracellular space by subtraction of the [14C]sucrose Vo. For studies with the e25I]A~fraction, the extracellular space was removed by centrifugation, similar to the method of Teuscher et a!. (9) . 125 1 and 14C permeability values were calculated from the linear portion of the uptake curves. Apparent permeability (Papp) was calculated for cell monolayers on filters and for empty filters with the following equation:
where VReceiver is the volume of the receiver chamber; A filten the filter surface area; COonan the initial concentration in the donor chamber; and 8CReceiver/8T, the change in the receiver chamber concentration over time. Monolayer permeability (PE) was determined from the Papp values of the cells and blank filters as:
Results were analyzed by linear regression or one-way ANOVA with post-hoc comparison by Dunnett's or Bonferroni's tests. In cases of unequal variance among treatment groups, results were analyzed by t test with correction for unequal variance.
Results
Uptake of [125I]A~in isolated rat choroid plexus was linear to 5 mins, after which it tapered ( Fig. l A) , The total [ 125I]labeled species in the tissue, derived solely from [125I]A~added in the artificial CSF, were three times more abundant than intact [125I]A~in the tissue. The uptake of a constant concentration of [125I]A~remained steady across the first 500-fold increase in unlabeled A~concentration (Fig. IB) . Only at the very highest concentration (1000 ng! ml or 0.23 J.lM of A~) did the unlabeled A~begin to compete with the tracer. The e25I]A~uptake at 1000 ng/ml was only 50% of the uptake at 500 ng/ml (0.05 :t 0.0 I vs.
Ac 0.10 :t 0.01 ml/g, respectively). In contrast, adding unlabeled A~produced a significant. linear increase in accumulation of the total 125 1 label (Fig. IB) .
Despite testing many treatments hypothesized to block energy-dependent cell functions (azide, vanadate, low temperature), to solubilize A~(TTR, ApoE3), to cause the precipitation of A~(Zn, Cu, anti-TTR), or to block putative A~transporters (anti-RAGE, anti-TTR), only the presence of apolipoprotein E (ApoE) and completing the experiment on ice were able to significantly change A~uptake (Fig. 2) . ApoE3 significantly decreased the uptake of total 1251 label by 49% at 14 nM and 79% at 280 nM (P < 0.05) ( Fig. 2A) but had a marginal, statistically insignificant 27% decrease of [1251]A~uptake (Fig. 2B ). Uptake of total 125 1 label was reduced by 90% on ice, but uptake of lI251]A~was reduced by only 50%.
In primary cell culture studies, the flux of 1251 label was linear in both directions up to I or 2 hrs, after which it tapered to steady-state conditions (Fig. 3 ). [12511A~and total 125 1 label fluxes were not determined separately because it was not possible to distinguish if unbound 125} was released from intact [1251]A~that had entered the cells or if it entered directly from the medium. The [14C]sucrose permeability appears higher in influx studies (from the outer to the inner chamber) than in efflux studies (Table I) 
Discussion
This study uses two distinctive techniques to demonstrate that the choroid plexus sequesters A~from an artificial CSF. allows for complete control of the fluid surrounding the tissue. Primary cultures grown in Transwells produce a monolayer of polarized epithelial cells in which the cells orient in the same direction. This allows one to uniquely examine transport and uptake from either the blood-facing or the CSF-facing membranes of these choroidal cells .
The accumulation of A~by the BCB at the choroid plexus is demonstrated by five distinct characteristics. First, the choroid plexus takes up the intact A~species, but not dissociated 125 1 or the small fragments of [125I]A~present in the artificial CSF. If all uptake were attributable to free 125 1 that had dissociated from the A~, then total Yo would have been much greater than observed, nearing the reported 10 ml/g (10) ; the time course graphs in Figure lA would have risen to the same maximal level; and the addition of unlabeled A~would have very little effect on free iodine uptake, as the two molecules are likely to have very different transport mechanisms.
Second, the A~uptake into the choroid plexus occurs rapidly and by a nondiffusional uptake process. The Aũ ptake reached maximum within 2-5 mins and exceeded that of a reference compound, [14C]sucrose, which crosses the choroid epithelium only by diffusion (II). The reduced uptake at low temperature as observed here (Fig. 2) and in previous experiments (12) is consistent with a nondiffusional, energy-dependent mechanism. The addition of azide or vanadate, which inhibit ATP production and use, respectively, failed to inhibit A~uptake, suggesting that the A~uptake by the choroid plexus is not ATP-dependent but rather relies on another driving force. In vivo CSF clearance of A~following its intracerebrovascular injection into rats was reported to be rapid (13) and is consistent with nondiffusional uptake by the BBB and/or BCB.
Third, the choroid plexus has a large storage capacity for A~. [1251]A~uptake was reduced only by unlabeled Aã t a total concentration of 0.23 /lM. This accumulation may reflect storage of intact A~as well as metabolized Af ragments, as discussed below.
Fourth, the uptake of A~by the choroid plexus does not require several proteins with suggested roles in A~binding or transport, such as transthyretin (TTR), apolipoprotein E3 (ApoE3), and the receptor for advanced glycation endproducts (RAGE) ( Fig. 2A and B) . In brain, the choroid plexus is the exclusive producer of TTR, a thyroxine transporter that also binds A~and prevents amyloid aggregation (14) (15) (16) ). In the current study, neither TTR nor difference between influx and efflux penneabilities was much less with [1251]A~transport. After normalizing the 125 1 label permeability to that of [14C]sucrose, the efflux ratio of A~to sucrose permeability was about 33% higher than the influx ratio. 125 1 label accumulation in primary cells was concentrative from both directions, with diffusion-corrected distributions (based on total protein) that were significantly higher in efflux studies than in influx studies (Fig. 4) .
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A 0 A~uptake into the choroid plexus despite its establIshed role at the human BBB (12, 20) . Tissue pre-or cotreatment with antibody against RAGE had no effect on A~uptake by . di . and zinc two metal the choroid plexus. In ad inon, copper ,
. ions found in A~plaques, did not affect A~uptake at concentrations known to precipitate the peptide (21) . . Finally, A~uptake by the choroid plexus favors ItS efflux from CSF to blood rather than its influx from blood to the CSF. The directionality of A~uptake was investigated in a Transwell system, in which the choroidal cells~rew with the CSF-facing (apical) side oriented toward the mner chamber and the blood-facing (basolateral) side toward. t.he outer chamber (8, 22) . The [14C]sucrose permeabJllty .
. , di th . efflux studies (Table appears higher m influx stu ies an 10 . " . b ier may be more I), suggestmg that the In Viti 0 am . permeable to incoming sucrose than to outg?l.n g sucrose. This unexpected difference in sucrose permeability may be a result of the presence of microvilli on the apical surface. of the BCB model, which increase the surface area~nd~rov~de crypt-like pockets that trap sucrose and hinder Its diffusion between cells. The difference between influx and efflux . h [ J251]Af.l transport Thus permeabilities was much less Wit 1 -' . " in contrast to the space marker sucrose, the bamer appears to be more permeable to outgoing A~than to incoming A~.
A net efflux of A~at the BCB is further supported by the residual A~accumulation studies. Total 125 1 label accumulation in primary cells was concentrative from both directions and was significantly higher in efflux studies than in influx studies (Fig. 4) . Thus, these studies clearly demonstrate that the normal choroid plexus removes AP from the CSF, suggesting a novel pathway for brain to maintain A~homeostasis in the CSF.
Our results further suggest that the choroid plexus may metabolize A~into smaller fragments following initial uptake. There were three times more total [ 125l]labeled species in the tissue than intact 1125I]A~following addition of 1125I]A~to the artificial CSF. This suggests that the choroid plexus may break down or metabolize A~into smaller fragments that it subsequently accumulates, which is consistent with a report that A~remains largely intact following injection into ventricular CSF but is partly degraded during or after clearance into blood (13) . Thus, a unique mechanism(s) must exist that functions to break down or metabolize A~to smaller fragments in the choroid plexus. Identification and characterization of Ap metabolism at the choroid plexus would permit a better understanding of how brain handles excess A~.
Although the purpose of this study was to investigate the role of the choroid plexus in removal of A~from the CSF and not the exact molecular species accumulated within the choroid plexus cells, the question of the specific molecule(s) that accumulates or aggregates in the choroid plexus indeed deserves further exploration. Several studies have suggested that the toxic moieties involved in Alzheimer's disease damage are small aggregates and not the free monomers of Ap peptides (23) (24) (25) . It is unclear, however. if the small aggregates are present in the CSF and whether the aggregates found in the choroid plexus cells (7) are derived from the monomer of A~or directly from small aggregates in the CSF. Because A~is the precursor of the aggregates, the removal of it from the CSF would presumably influence the homeostasis of A~in the brain. If the choroid plexus accumulates only the monomer forms of A~and not the larger aggregates associated with AD, then perhaps the tissue plays only a limited role in AD causation and/or progression. It will be important in the future to identify the molecular species of A~that are taken into the choroid plexus from CSF to further elucidate the tissue's role in AD.
In summary, the isolated choroid plexus accumulates A~from the CSF through an energy-dependent, nondiffusional pathway. Net flux across the choroid plexus appears to favor efflux from the CSF to blood. These results demonstrate a significant role of choroid plexus in cleansing A~from CSF and maintaining homeostasis of A~in brain extracellular fluid and should be of interest to AD researchers and clinicians. 
